Related Experiment Video
Updated: Mar 6, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist
K L Carter1, A D Gabrellas2, S Shah3
1Penn Center for Primary Care, University of Pennsylvania Health System, Philadelphia, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania.
Setting:
Primary care clinic for refugees, Philadelphia, Pennsylvania, USA.
Objective:
To assess the effect of a clinical pharmacist-run clinic for latent tuberculous infection (LTBI) on LTBI treatment completion rates in refugee patients.
Design:
In 2012, a pharmacist-run LTBI clinic was established to improve adherence and completion rates among refugees. Before 2012, LTBI treatment completion rates were less than 30%. A structured model was developed to efficiently track patients and ensure completion within specified time ranges. Interventions made by the pharmacist were recorded. Completion reports were forwarded to the Philadelphia Department of Health for tracking and statistical purposes.
Results:
Between 2012 and 2016, of 436 refugee patients screened, 121 (27.8%) were diagnosed with LTBI and 103 were referred to the pharmacist-run LTBI clinic to initiate treatment. Of those referred, 94% successfully completed LTBI treatment within the designated time frame, 40% of whom required an intervention from the pharmacist to remain adherent.
Conclusion:
LTBI treatment completion rates more than tripled after the implementation of a pharmacist-run LTBI clinic. This successful model indicates that incorporating clinical pharmacists into interdisciplinary health care teams can enhance medication adherence and completion rates in refugee populations, leading to improved public health outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Therapeutic Drug Monitoring: Affecting Factors

